Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry

Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry Publisher Pubmed

Vitolo M^{1, 2, 3} ; Proietti M^{2, 4, 5} ; Malavasi VL¹ ; Bonini N^{1, 2} ; Romiti GF^{2, 6} ; Imberti JF^{1, 2, 3} ; Fauchier L⁷ ; Marin F⁸ ; Nabauer M⁹ ; Potpara TS^{10, 11} ; Dan GA^{12, 42} ; Kalarus Z¹³ ; Maggioni AP¹⁴ ; Lane DA^{2, 15} Show All Authors

Vitolo M^{1, 2, 3}
Proietti M^{2, 4, 5}
Malavasi VL¹
Bonini N^{1, 2}
Romiti GF^{2, 6}
Imberti JF^{1, 2, 3}
Fauchier L⁷
Marin F⁸
Nabauer M⁹
Potpara TS^{10, 11}
Dan GA^{12, 42}
Kalarus Z¹³
Maggioni AP¹⁴
Lane DA^{2, 15}
Lip GYH^{2, 15, 45}
Boriani G¹
Marin F⁸
Goda A¹⁶
Mairesse G¹⁷
Shalganov T¹⁸
Antoniades L¹⁹
Taborsky M²⁰
Riahi S²¹
Muda P²²
Bolao IG²³
Piot O²⁴
Etsadashvili K²⁶
Simantirakis EN²⁷
Haim M²⁸
Azhari A²⁹
Najafian J²⁹
Santini M³⁰
Mirrakhimov E³¹
Kulzida K³²
Erglis A³³
Poposka L³⁴
Burg MR³⁵
Crijns H³⁶
Erkuner O³⁶
Atar D³⁷
Lenarczyk R³⁸
Oliveira MM³⁹
Shah D⁴⁰
Serdechnaya E⁴¹
Diker E⁴⁴
Lane D⁴⁵

Show Affiliations

1. Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, Modena, 41124, Italy
2. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
3. Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
4. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
5. Geriatric Unit, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy
6. Department of Translational and Precision Medicine, Sapienza – University of Rome, Rome, Italy
7. Service de Cardiologie, Centre Hospitalier Universitaire Trousseau, Tours, France
8. Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, CIBERCV, Murcia, Spain
9. Department of Cardiology, Ludwig-Maximilians-University, Munich, Germany
10. School of Medicine, University of Belgrade, Belgrade, Serbia
11. Intensive Arrhythmia Care, Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia
12. Carol Davila' University of Medicine, Colentina University Hospital, Bucharest, Romania
13. Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia, Katowice, Silesian Centre for Heart Diseases, Zabrze, Poland
14. ANMCO Research Center, Firenze, Italy
15. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
16. University Hospital Center Mother Tereza, Tirana, Albania
17. Cliniques du Sud-Luxembourg, Arlon, Belgium
18. National Heart Hospital, Sofia, Bulgaria
19. Nicosia General Hospital, Latsia, Cyprus
20. University Hospital Olomouc, Olomouc, Czech Republic
21. Aalborg University Hospital, Aalborg, Denmark
22. University of Tartu, Tartu, Estonia
23. Navarra Institute for Health Research, Pamplona, Spain
24. Centre Cardiologique du Nord, Saint-Denis, France
25. Ludwig-Maximilians-University, Munich, Germany
26. G. Chapidze Emergency Cardiology Center, Tbilisi, Georgia
27. University Hospital of Heraklion, School of Medicine, University of Crete, Heraklion, Crete, Greece
28. Soroka Medical Center, Beer Sheva, Israel
29. Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
30. San Filippo Neri Hospital, Rome, Italy
31. National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
32. Scientific-Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
33. Pauls Stradins Clinical University Hospital University of Latvia Riga Latvia, Latvia
34. University Clinic of Cardiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, North Macedonia
35. Mater Dei Hospital, Triq Dun Karm Psaila, Malta
36. Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, Netherlands
37. Oslo University Hospital Ulleval and Institute of Clinical Sciences, University of Oslo, Oslo, Norway
38. Silesian Center for Heart Disease, Zabrze, Poland
39. Hospital Santa Marta, Lisbon, Portugal
40. Department of Medicine Specialities, University Hospital Geneva, Geneva, Switzerland
41. Colentina University Hospital, Bucharest, Romania
42. Northern State Medical University, Arkhangelsk, Russian Federation
43. Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia
44. Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
45. City Hospital, University of Birmingham, Birmingham, United Kingdom

Source: European Journal of Internal Medicine Published:2022

Abstract

Background: Implementation of the Atrial fibrillation Better Care (ABC) pathway is recommended by guidelines on atrial fibrillation (AF), but the impact of adherence to ABC pathway in patients with cancer is unknown. Objectives: To investigate the adherence to ABC pathway and its impact on adverse outcomes in AF patients with cancer. Methods: Patients enrolled in the EORP-AF General Long-Term Registry were analyzed according to (i) No Cancer; and (ii) Prior or active cancer and stratified in relation to adherence to the ABC pathway. The composite Net Clinical Outcome (NCO) of all-cause death, major adverse cardiovascular events and major bleeding was the primary endpoint. Results: Among 6550 patients (median age 69 years, females 40.1%), 6005 (91.7%) had no cancer, while 545 (8.3%) had a diagnosis of active or prior cancer at baseline, with the proportions of full adherence to ABC pathway of 30.6% and 25.7%, respectively. Adherence to the ABC pathway was associated with a significantly lower occurrence of the primary outcome vs. non-adherence, both in ‘no cancer’ and ‘cancer’ patients [adjusted Hazard Ratio (aHR) 0.78, 95% confidence interval (CI): 0.66–0.92 and aHR 0.59, 95% CI 0.37–0.96, respectively]. Adherence to a higher number of ABC criteria was associated with a lower risk of the primary outcome, being lowest when 3 ABC criteria were fulfilled (no cancer: aHR 0.54, 95%CI: 0.36–0.81; with cancer: aHR 0.32, 95% CI 0.13–0.78). Conclusion: In AF patients with cancer enrolled in the EORP-AF General Long-Term Registry, adherence to ABC pathway was sub-optimal. Full adherence to ABC-pathway was associated with a lower risk of adverse events © 2022

2. Evaluation of the Effect of Adherence to Treatment Regimen Program on Quality of Life in Atrial Fibrillation Patients Hospitalized in Shahid Chamran Hospital in Isfahan in 2017, Revista Latinoamericana de Hipertension (2019)

3. Antithrombotic Therapy in Atrial Fibrillation Associated With Valvular Heart Disease: A Joint Consensus Document From the European Heart Rhythm Association (Ehra) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the Esc Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (Cassa), Heart Rhythm Society (Hrs), Asia Pacific Heart Rhythm Society (Aphrs), South African Heart (Sa Heart) Association and Sociedad Latinoamericana De Estimulacion Cardiaca Y Electrofisiologia (Soleace), Europace (2017)

Experts (# of related papers)

View all Related Experts

Davood Shafie (1)

Nizal Sarrafzadegan (1)

Style	Citing Format
MLA	Vitolo M, et al.. "Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry." European Journal of Internal Medicine, vol. 105, no. , 2022, pp. 54-62.
APA	Vitolo M, Proietti M, Malavasi VL, Bonini N, Romiti GF, Imberti JF, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Kalarus Z, Maggioni AP, Lane DA, Lip GYH, Boriani G, Marin F, Goda A, Mairesse G, ... Lane D (2022). Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry. European Journal of Internal Medicine, 105(), 54-62.
Chicago	Vitolo M, Proietti M, Malavasi VL, Bonini N, Romiti GF, Imberti JF, Fauchier L, et al.. "Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry." European Journal of Internal Medicine 105, no. (2022): 54-62.
Harvard	Vitolo M et al. (2022) 'Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry', European Journal of Internal Medicine, 105(), pp. 54-62.
Vancouver	Vitolo M, Proietti M, Malavasi VL, Bonini N, Romiti GF, Imberti JF, et al.. Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry. European Journal of Internal Medicine. 2022;105():54-62.
BibTex	@article{ author = {Vitolo M and Proietti M and Malavasi VL and Bonini N and Romiti GF and Imberti JF and Fauchier L and Marin F and Nabauer M and Potpara TS and Dan GA and Kalarus Z and Maggioni AP and Lane DA and Lip GYH and Boriani G and Marin F and Goda A and Mairesse G and Shalganov T and Antoniades L and Taborsky M and Riahi S and Muda P and Bolao IG and Piot O and Etsadashvili K and Simantirakis EN and Haim M and Azhari A and Najafian J and Santini M and Mirrakhimov E and Kulzida K and Erglis A and Poposka L and Burg MR and Crijns H and Erkuner O and Atar D and Lenarczyk R and Oliveira MM and Shah D and Serdechnaya E and Diker E and Lane D}, title = {Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry}, journal = {European Journal of Internal Medicine}, volume = {105}, number = {}, pages = {54-62}, year = {2022} }
RIS	TY - JOUR AU - Vitolo M AU - Proietti M AU - Malavasi VL AU - Bonini N AU - Romiti GF AU - Imberti JF AU - Fauchier L AU - Marin F AU - Nabauer M AU - Potpara TS AU - Dan GA AU - Kalarus Z AU - Maggioni AP AU - Lane DA AU - Lip GYH AU - Boriani G AU - Marin F AU - Goda A AU - Mairesse G AU - Shalganov T AU - Antoniades L AU - Taborsky M AU - Riahi S AU - Muda P AU - Bolao IG AU - Piot O AU - Etsadashvili K AU - Simantirakis EN AU - Haim M AU - Azhari A AU - Najafian J AU - Santini M AU - Mirrakhimov E AU - Kulzida K AU - Erglis A AU - Poposka L AU - Burg MR AU - Crijns H AU - Erkuner O AU - Atar D AU - Lenarczyk R AU - Oliveira MM AU - Shah D AU - Serdechnaya E AU - Diker E AU - Lane D TI - Adherence to the “Atrial Fibrillation Better Care” (Abc) Pathway in Patients With Atrial Fibrillation and Cancer: A Report From the Esc-Ehra Eurobservational Research Programme in Atrial Fibrillation (Eorp-Af) General Long-Term Registry JO - European Journal of Internal Medicine VL - 105 IS - SP - 54 EP - 62 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract